Last reviewed · How we verify

Avaxim 80U Pediatric: Inactivated Hepatitis A Virus

Sanofi Pasteur, a Sanofi Company · FDA-approved active Biologic Quality 2/100

Avaxim 80U Pediatric: Inactivated Hepatitis A Virus is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company. It is currently FDA-approved. Also known as: Avaxim 80U Pediatric.

At a glance

Generic nameAvaxim 80U Pediatric: Inactivated Hepatitis A Virus
Also known asAvaxim 80U Pediatric
SponsorSanofi Pasteur, a Sanofi Company
ModalityBiologic
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Avaxim 80U Pediatric: Inactivated Hepatitis A Virus

What is Avaxim 80U Pediatric: Inactivated Hepatitis A Virus?

Avaxim 80U Pediatric: Inactivated Hepatitis A Virus is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company.

Who makes Avaxim 80U Pediatric: Inactivated Hepatitis A Virus?

Avaxim 80U Pediatric: Inactivated Hepatitis A Virus is developed and marketed by Sanofi Pasteur, a Sanofi Company (see full Sanofi Pasteur, a Sanofi Company pipeline at /company/sanofi).

Is Avaxim 80U Pediatric: Inactivated Hepatitis A Virus also known as anything else?

Avaxim 80U Pediatric: Inactivated Hepatitis A Virus is also known as Avaxim 80U Pediatric.

What development phase is Avaxim 80U Pediatric: Inactivated Hepatitis A Virus in?

Avaxim 80U Pediatric: Inactivated Hepatitis A Virus is FDA-approved (marketed).

Related